Publication | Open Access
<i>In Vitro</i> Activity of Ceftolozane-Tazobactam as Determined by Broth Dilution and Agar Diffusion Assays against Recent U.S. Escherichia coli Isolates from 2010 to 2011 Carrying CTX-M-Type Extended-Spectrum β-Lactamases
28
Citations
23
References
2014
Year
Antimicrobial SusceptibilityBroth DilutionAntibioticsCeftolozane Mic50/mic9MedicineCeftolozane MicAnalytical ChemistryAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyInfection ControlCtx-m-type Extended-spectrum β-LactamasesAgar Diffusion AssaysClinical MicrobiologyAntimicrobial ResistanceCeftolozane-tazobactam Disks
Ceftolozane MIC(50)/MIC(90)s were 4/8 μg/ml when tested against 26 CTX-M-14-type-producing isolates and 64/>64 μg/ml against 219 CTX-M-15-type-producing isolates. The addition of 4 μg/ml tazobactam lowered the ceftolozane MIC50/MIC9(0)s to ≤ 0.25/0.5 μg/ml by broth microdilution and Etest. The zone diameters for the ceftolozane-tazobactam disks were 23 to 29 mm for 92.2% of the isolates.
| Year | Citations | |
|---|---|---|
Page 1
Page 1